ABT 526

Known as: ABT-526, ABT526 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2005
0120032005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PURPOSE The angiogenic phenotype of malignant cancers has been established as a target for cancer therapy. ABT-526 and ABT-510… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2006
2006
PURPOSE Thrombospondin-I (TSP-I) is a natural antiangiogenic protein that enhances apoptosis of activated endothelial cells. A… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2005
2005
The heptapeptide 1, NAc-Gly-Val-DIle-Thr-Arg-Ile-ArgNHEt, a structurally modified fragment derived from the second type-1 repeat… (More)
Is this relevant?
2004
2004
Um zu untersuchen, ob zwischen den Wirkungen physiologisch vorkommender chemischer Reize auf die Salzs£uresekretion des Magens… (More)
Is this relevant?
2004
2004
3088 Background: Thrombospondin-1 (TSP-1) is a natural antiangiogenic protein that enhances apoptosis of activated endothelial… (More)
Is this relevant?
2003
2003
Previous gene targeting studies have implicated an indispensable role of vascular endothelial growth factor (VEGF) in tumor… (More)
Is this relevant?